The European Union knows for what ...

The European Union knows for what reason important clinical trials are as well-as; not only-but also; not only-but; not alone-but to the health of patients and to the health of the pharmaceutical industry in Europe in like manner the last few weeks have seen intense European regulatory activity the couple at strategic and tactical evens in a bid to make sure that patients can continue to benefit from high-quality medicines from a competitive and innovative European industry.
Strategy
At the strategic on a level senior European Union officials came not at home in early July with what is intended as an evolving document for the yet to be of the industry. The document is